The present study showed thatimmunomodulation targetting NF-κB, by blocking the protein via pimecrolimus showed complex stability towards the end of the 100ns simulation, with conformational changes induced, pointing towards a potential NF-κB inhibition in COVID-19 surge. Here, NFKB1 is linked to COVID-19.